Cargando…
Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling
BACKGROUND: Pancreatic cancer (PC) is aggressive and with poor clinical prognosis. However, mechanisms underlying the aggressiveness of PC remain unclear. Increasing evidence indicates that cholesterol, a major source of bio-energy, is required for the progression of human cancers including PC. Ther...
Autores principales: | Cai, Shang, Chen, Qingqing, Xu, Yingying, Zhuang, Qianfeng, Ji, Shengjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798715/ https://www.ncbi.nlm.nih.gov/pubmed/35117491 http://dx.doi.org/10.21037/tcr.2020.01.27 |
Ejemplares similares
-
Neurotrophins and Neurotrophin Receptors in Adult Brain Plasticity
por: Hefti, Franz, et al.
Publicado: (1992) -
Neurotrophins and Neurotrophin Receptors in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013) -
Atorvastatin-induced pancreatitis
por: Prajapati, Samir, et al.
Publicado: (2010) -
Atorvastatin-induced acute pancreatitis
por: Deshpande, Prasanna R., et al.
Publicado: (2011) -
Suppression of asparaginyl endopeptidase attenuates breast cancer-induced bone pain through inhibition of neurotrophin receptors
por: Yao, Peng, et al.
Publicado: (2017)